Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 14 studies | 24% ± 3% | |
lung | 10 studies | 33% ± 20% | |
kidney | 9 studies | 30% ± 9% | |
intestine | 9 studies | 24% ± 9% | |
lymph node | 5 studies | 32% ± 7% | |
pancreas | 4 studies | 48% ± 12% | |
liver | 4 studies | 23% ± 7% | |
thymus | 3 studies | 51% ± 23% | |
brain | 3 studies | 21% ± 4% | |
breast | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1499.91 | 653 / 653 | 100% | 116.36 | 602 / 605 |
pancreas | 100% | 746.67 | 328 / 328 | 99% | 154.45 | 177 / 178 |
intestine | 100% | 1276.44 | 963 / 966 | 100% | 122.44 | 525 / 527 |
lung | 99% | 776.14 | 574 / 578 | 100% | 115.07 | 1150 / 1155 |
prostate | 100% | 901.19 | 245 / 245 | 98% | 55.19 | 493 / 502 |
stomach | 99% | 1442.01 | 354 / 359 | 99% | 95.07 | 283 / 286 |
breast | 99% | 786.56 | 456 / 459 | 98% | 63.93 | 1098 / 1118 |
kidney | 100% | 3981.57 | 89 / 89 | 97% | 179.98 | 876 / 901 |
adrenal gland | 100% | 1002.14 | 258 / 258 | 97% | 60.62 | 222 / 230 |
esophagus | 97% | 670.17 | 1403 / 1445 | 99% | 67.41 | 181 / 183 |
bladder | 95% | 652.67 | 20 / 21 | 99% | 115.75 | 499 / 504 |
uterus | 95% | 558.44 | 162 / 170 | 96% | 100.31 | 442 / 459 |
ovary | 92% | 378.39 | 166 / 180 | 98% | 66.62 | 423 / 430 |
liver | 100% | 1872.33 | 226 / 226 | 90% | 65.51 | 365 / 406 |
brain | 95% | 946.76 | 2512 / 2642 | 34% | 31.09 | 237 / 705 |
skin | 96% | 764.60 | 1736 / 1809 | 23% | 10.08 | 109 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 71.82 | 29 / 29 |
ureter | 0% | 0 | 0 / 0 | 100% | 51.79 | 1 / 1 |
spleen | 100% | 573.04 | 240 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 77.44 | 44 / 45 |
adipose | 97% | 480.79 | 1172 / 1204 | 0% | 0 | 0 / 0 |
heart | 93% | 374.75 | 797 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 78% | 486.31 | 1045 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 64% | 577.53 | 593 / 929 | 0% | 0 | 0 / 0 |
muscle | 21% | 52.63 | 171 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 11% | 3.55 | 9 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006897 | Biological process | endocytosis |
GO_0046427 | Biological process | positive regulation of receptor signaling pathway via JAK-STAT |
GO_0061484 | Biological process | hematopoietic stem cell homeostasis |
GO_0009617 | Biological process | response to bacterium |
GO_0005764 | Cellular component | lysosome |
GO_0005768 | Cellular component | endosome |
GO_0005794 | Cellular component | Golgi apparatus |
Gene name | OCIAD2 |
Protein name | OCIA domain-containing protein 2 (Ovarian carcinoma immunoreactive antigen-like protein) OCIA domain containing 2 |
Synonyms | |
Description | |
Accessions | ENST00000273860.8 [Q56VL3-2] ENST00000381464.6 ENST00000508632.6 [Q56VL3-1] ENST00000620187.4 [Q56VL3-2] J3KPI9 Q56VL3 ENST00000510159.1 D6RD77 |